Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA) Summary Review Memos for 180-Day Design Changes
  • Print
  • Share
  • E-mail
-

As a pilot program under the CDRH Transparency Initiative, FDA has begun releasing some summary review memos for 180-day PMA supplements relating to design changes. Links to all available summary review memos can be found here.

Learn more...

51 to 55 of 325 records
 < 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 > 
results per page
Device
Name
Sort by Device Name [A-Z]
Sort by Device Name [Z-A]
PMA
Number
Sort by PMA Number [0-9]
Sort by PMA Number [9-0]
Decision
Date
Sort by Decision Date [0-9]
Sort by Decision Date [9-0]
Review
Memo		 Approval
Order
cellpaker plasma collection device P050044/S019 01/31/2012 Review Approval
juvederm ultra xc and juvederm ultra plus xc P050047/S005 01/07/2010 Review Approval
restylane/restylane-l/ perlane/ perlane-l , restylane silk(injectable gels) P040024/S079 01/26/2016 Review  
restylane injectable gel P040024/S052 07/18/2011 Review Approval
restylane l and perlane l injectable gels P040024/S039 01/29/2010 Review Approval
Other Databases
-
-